Physician

Evelena Ontiveros, MD PHD

According to 2025 Medicare claims, Evelena Ontiveros, MD PHD (NPI: 1689886962) practices hematology/oncology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62526-5858. Ontiveros is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Ontiveros' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 613 traditional Medicare patients, billed 182,322 HCPCS/CPT codes, and received $1,973,056 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,441 prescription claims across 366 beneficiaries totaling $5,783,987 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 81 claims. Open Payments data shows 25 records totaling $554. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $40,552 to $1,973,056. Similarly, Part D prescription costs have risen steadily, from $1,025,992 to $5,783,987. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$987K$2.0M2015 Medicare payment: $40,552 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $52,085 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $201,127 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $617,618 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $853,426 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,364,172 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,350,852 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,371,022 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,326,928 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,973,056 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201586626$40,552
2016104866$52,085
201726013,059$201,127
201839756,250$617,618
201947583,331$853,426
2020438111,827$1,364,172
2021518139,213$1,350,852
2022511175,151$1,371,022
2023463137,141$1,326,928
2024613182,322$1,973,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.9M$5.8M2015 Drug cost: $1,025,992 (USD; Tot_Drug_Cst)2016 Drug cost: $1,662,559 (USD; Tot_Drug_Cst)2017 Drug cost: $1,294,946 (USD; Tot_Drug_Cst)2018 Drug cost: $644,468 (USD; Tot_Drug_Cst)2019 Drug cost: $969,192 (USD; Tot_Drug_Cst)2020 Drug cost: $882,181 (USD; Tot_Drug_Cst)2021 Drug cost: $1,286,097 (USD; Tot_Drug_Cst)2022 Drug cost: $1,750,046 (USD; Tot_Drug_Cst)2023 Drug cost: $3,304,501 (USD; Tot_Drug_Cst)2024 Drug cost: $5,783,987 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201528159$1,025,992
201637220$1,662,559
201796378$1,294,946
2018165841$644,468
20191861,027$969,192
20202011,265$882,181
20212271,684$1,286,097
20223002,003$1,750,046
20233011,918$3,304,501
20243662,441$5,783,987

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.7K$5.4K2017 Medicare payment: $207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $886 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $683 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,512 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,369 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$207
2018N/R16$886
2019N/R12$683
2020N/R35$1,512
2021N/R81$5,369
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4821,411$90
80053Blood test, comprehensive group of blood chemicals255883$10
36415Insertion of needle into vein for collection of blood sample3541,155$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count250528$8
83540Iron level231410$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide521,414$861,049
ImbruvicaIbrutinib541,554$716,192
VerzenioAbemaciclib31868$414,180
CalquenceAcalabrutinib Maleate22660$305,566
BrukinsaZanubrutinib23690$300,659

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$554Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Evelena Ontiveros, MD PHD?

Tedicare shows public-source Medicare data for Evelena Ontiveros, MD PHD (NPI 1689886962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Evelena Ontiveros, MD PHD have ACO affiliation data?

Evelena Ontiveros, MD PHD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Evelena Ontiveros, MD PHD?

Evelena Ontiveros, MD PHD is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Evelena Ontiveros, MD PHD have Open Payments data?

Evelena Ontiveros, MD PHD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.